ALLO vs GL · rev $22.0K vs P/E 10, $10.26B cap
Allogene Therapeutics Inc (ALLO) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
GL does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the ALLO and GL stock pages for the full models.
Not investment advice.